Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alanyl-tRNA synthetase 1 pseudogene 1 (AARS1P1) is classified as a pseudogene, specifically a non-functional genomic segment related to the protein-coding gene alanyl-tRNA synthetase 1 (AARS1)[1][6][7]. Unlike its parent gene AARS1, which encodes an enzyme essential for attaching alanine to tRNA during protein biosynthesis, AARS1P1 does not produce a functional protein product and is not associated with any known physiological or disease process. There is no evidence supporting any drug interaction, disease role, biomarker utility, or therapeutic targeting for AARS1P1[6][7]. AARS1P1 should not be confused with the functional AARS1 gene, which plays important roles in translation and certain pathologies, but AARS1P1 itself has no established function or relevance as a therapeutic target[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alanyl-tRNA synthetase 1 pseudogene 1 (AARS1P1).